MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 23751-23760 Newer>
The Motley Fool
June 6, 2007
Wimm-Bill-Dann Provides Juicy Numbers: Fool by Numbers The Russian dairy and juice manufacturer released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles 2089 similar articles
The Motley Fool
June 6, 2007
Emil Lee
Finding Value With Joe Feshbach How hedge fund manager Joe Feshbach invests in crisis situations. Not only does Feshbach invest in companies that make other investors' stomachs turn, he also runs an extremely concentrated portfolio with five to 10 positions. mark for My Articles 11 similar articles
The Motley Fool
June 6, 2007
Guess? Again: Fool by Numbers The clothier released first-quarter 2008 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles 2199 similar articles
The Motley Fool
June 6, 2007
Ryan Fuhrmann
Foolish Forecast: Bio-Reference Labs Nudges Competitors The clinical laboratory testing company is set to release it second-quarter earnings report. Investors, here is what you can expect to see. mark for My Articles 32 similar articles
The Motley Fool
June 6, 2007
Brian Orelli
Cure Your Cancer or Your Money Back Janssen-Cilag, a subsidiary of Johnson & Johnson, has recently offered to refund the cost of Velcade to the British National Health Service if the patient fails to respond to its multiple myeloma drug. Drug-company investors need not worry about these kinds of deals. mark for My Articles 263 similar articles
The Motley Fool
June 6, 2007
David Lee Smith
Private Comcast, Sir? Will Comcast be one of the many cable companies to go private? Individuals with an appetite for media investments would do well to consider buying shares in this unusually solid company. mark for My Articles 517 similar articles
The Motley Fool
June 6, 2007
Brian Lawler
Is Telik Insane? Shares of Telik fall after the FDA puts a halt to trials with its lead drug. Even at this reduced share price, investors should stay far away from this pharma. mark for My Articles 73 similar articles
The Motley Fool
June 6, 2007
Alyce Lomax
Panera Pummeled The bread maker gets flattened by a less tasty outlook. Investors, take note. mark for My Articles 124 similar articles
The Motley Fool
June 6, 2007
Tim Beyers
There's Your Dow Jones Bidding War Billionaire Ron Burkle stepped in the way of a proposed buyout of the publisher by News Corp. So far, Burkle has acted prudently in refusing to overpay for dwindling media assets. Good for him. But Dow Jones isn't dwindling; it's growing and earning decent margins as a result. mark for My Articles 210 similar articles
The Motley Fool
June 6, 2007
Steven Mallas
Not Tempted by New Frontier Media The adult entertainment company's results weren't as enticing as its products. Investors may want to hold off on beginning an investment here. mark for My Articles 112 similar articles
<Older 23751-23760 Newer>    Return to current articles.